Pro Traders Forum

[gumzsa]

gn pros

[gumzsa]

gm pros

[TradeForProfits]

$PBIO video of water-soluble #CBD, Lab opening news:

CBD-water UST demo video: http://go.pardot.com/l/703933/2020-02-26/2qpvf

https://finance.yahoo.com/news/pressure-biosciences-launches-era-preparation-131500081.html

Pressure BioSciences Launches New Era in Preparation of Water-Soluble Nanoemulsions, for CBD and Other Valuable Oils, with Opening of UST Demonstration Laboratory
PR Newswire PR NewswireFebruary 27, 2020
NEW UST Video Release - Solving Complex Formulation & Processing Challenges By Creating High Quality CBD Oil Nanoemulsions Using Physics not Chemistry

SOUTH EASTON, Mass., Feb. 27, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, today announced the official opening of its new Ultra Shear Technology™ ("UST™") Demonstration Laboratory (the "UST Demo Lab"). The UST Demo Lab is located in the Company's South Easton, Massachusetts facility.

A major purpose of the UST Demo Lab is to showcase the ability of the Company's revolutionary UST Platform to process CBD oil into true, high quality, water-soluble nanoemulsions. It is expected that nanoemulsions of CBD will be more stable, have superior aesthetic quality, and offer higher bioavailability than the standard macro/microemulsions used in most CBD products today (Nanoemulsions, in Handbook of Nanomaterials in Industrial Applications, Ghodake and Patravale, 2018). A second purpose is to invite potential purchasers of the Company's UST-based BaroShear Systems (initial release expected Q4 2020) to evaluate how their CBD and other product formulations work with the Company's revolutionary UST platform.

This Company today released a new short video demonstrating how CBD oil from an independent manufacturer was processed into a clear, water-soluble nanoemulsion using a UST-based, first generation BaroShear system. The video shows the CBD oil and water mixture prior to and after UST processing.

Link to new short video showcasing the UST Demonstration Lab: PBI UST CBD Video 022720

CBD and other cannabinoids are extracted from the hemp plant in an oil form. The water-based biology of human bodies has difficulty accessing and absorbing oily molecules from ingested or topically applied hemp oil drops. According to Jason Ellis, President of Vegas CBD Factory, "My colleagues in the cannabis market are beginning to realize that high quality CBD products will only come by using high quality, water-soluble nanoemulsions of CBD oil, such as those generated from processing CBD Oil with PBI's UST™ platform, which I have observed first-hand in their lab."

Kenneth F. Micciche, Director of PBI's UST Program, said: "We processed samples of CBD oil formulations from several highly interested companies over the past two months, in an effort to optimize the service we announced today. The results speak for themselves: one group (Vegas CBD Factory) ordered six BaroShear K45 systems (for Q4 2020 delivery and installation). We believe several more companies who participated in the early evaluation process are close to giving us their purchase orders. The ability to showcase the UST platform in real life, and see the final product first-hand, has been shown to be vital to our marketing efforts. As has been said in the past: 'build it and they will come'. The opening of the UST Demo Lab is a critical accomplishment in our UST sales and marketing strategy."

Richard T. Schumacher, President and CEO of PBI commented: "The initial reactions from manufacturers of topical and ingestible cannabidiol products processed in our lab during the trial period have been extremely positive. They quickly saw how they could realize substantial cost reductions while eliminating the overloading of poorly water-soluble CBD and other cannabinoids into products to achieve targeted dosing levels. We believe our breakthrough technology platform provides them with a new-found ability to provide safe and effective dosing for their customers, which in turn should stimulate greater growth in the market for CBD-based products overall, and strong sales of our BaroShear product line when it is released to the market later this year."

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following website link:

http://www.pressurebiosciences.com

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gn pros

[gumzsa]

IRNG .0035 been holding

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gn pros

[$ B.M.F.$]

SPOM, merger news, company worth $143,000,000

[gumzsa]

gm pros

[TradeForProfits]

$KDNG Business Warrior takes over, set for growth phase:

https://www.businesswire.com/news/home/20200212005266/en/

Business Warrior Goes Public
Leader in Small Business Software Now Publicly Traded Under Ticker Symbol KDNG

February 12, 2020 09:00 AM Eastern Standard Time
TEMPE, Ariz.--(BUSINESS WIRE)--Business Warrior (OTC: KDNG) today announced that it has completed a reverse merger and is now a publicly traded company under the ticker symbol KDNG. All the filings have been brought up to date on OTCMarkets.com. This brings Business Warrior, formerly known as Bluume, one step closer to being the most trusted small business software in the United States.

“From the beginning, our team has always shared a passion for the small business community and developing solutions that help them achieve more success”

Tweet this
Business Warrior has achieved substantial market momentum and is on pace to grow 500% this year. They completed their first round of raising capital of $1 million through private investment. Now they’re closing on a large round of capital, which will be used to launch major advertising campaigns, scale operations, expand the software development team and make key acquisitions. Under new corporate structure, Business Warrior retains control of the company through newly issued preferred shares.

Business Warrior selected this route of financing the company for growth as opposed to other private equity opportunities presented to them. “This was the best way for us to scale quickly while maintaining full control of our software development. It’s essential that our software solution stays unbiased so that we continue to make the best possible recommendations to our small business clients to improve and grow their businesses,” said Business Warrior CEO Rhett Doolittle.

The Business Warrior platform makes recommendations to small businesses on the tasks they should accomplish in order to improve and grow. One feature that sets Business Warrior apart is showing each subscriber their business’s “ad readiness,” which tells them if they have major tasks to accomplish before launching marketing campaigns to maximize their ad spend. The recommendations get the business ready to grow or boosts growth, depending on the stage of the business. This solves a real problem for small businesses.

“With this public offering, we’re betting on ourselves to solve a real problem for small businesses,” said Doolittle. “We spent over five years testing every major software solution for small businesses in order to understand the struggles they go through regarding marketing and technology. There is a gap between the problem preventing small businesses from growing and the software solutions available today. Our solution is different than anything else on the market.”

Up to this point, Business Warrior has been self-funded and raised capital from friends and family. They found that taking the private equity route meant a potential loss of control and a delay in the time-to-market with their software. By now becoming a public company, they’re able to finance their growth plans while maintaining full control of their software, as well as their management team.

Business Warrior is Doolittle’s third startup, having achieved two successful exits prior to launching the company as Bluume in 2014. His first company, Entrust Bankcard, grew 8,417% in three years, earning a #18 position on Inc. Magazine’s list of the 500 fastest-growing companies in the U.S. He’s more passionate than ever and has a plan to scale Business Warrior faster than his previous record-setting pace. “From the beginning, our team has always shared a passion for the small business community and developing solutions that help them achieve more success,” Doolittle explained.

About Business Warrior

Business Warrior software helps small businesses simplify and prioritize daily decisions to improve profitability. Business Warrior takes an organic view of each business’s online reputation, listings, website, search results, and advertising. Then the software recommends the imperative actions to drive new customers and improve profitability. OTCMarkets.com information will be updated in the coming weeks. For more information, please visit businesswarrior.com.



Contacts
PR: Ali Nagy
[e-mail]
[phone]

Investor Relations: Jonathan Brooks
[e-mail]
[phone]

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[pennyonfire]

WDLF .003

[gumzsa]

gm pros

[TradeForProfits]

$IQST expands #5G team, tops $22M in 2019 #revenues and more:

https://finance.yahoo.com/news/iqstel-inc-announces-5g-infrastructure-103010356.html

IQSTEL, Inc. Announces that 5G Infrastructure Expert Jose Antonio Abdo will Join the Company as an Advisor to the Board of Directors
GlobeNewswire GlobeNewswireFebruary 10, 2020
NEW YORK, NY, Feb. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – iQSTEL, Inc. (IQST) is pleased to announce the immediate addition of Mr. Jose Antonio Abdo, an expert in 5G infrastructure, as an advisor to the board of directors.

iQSTEL, Inc.:5G Networks Worldwide by 2021
https://s.yimg.com/ny/api/res/1.2/Dkv6vyh2MTDXhUbyS1PJyA--~A/YXBwaWQ9aGlnaGxhbmRlcjtzbT0xO3c9ODAwO2lsPXBsYW5l/http://globalfinance.zenfs.com/en_us/Finance/US_AFTP_GlobeNewsWire_EmailNotif_LIVE/iqstel-inc.jpg">https://s.yimg.com/ny/api/res/1.2/Dkv6vyh2MTDXhUbyS1PJyA--~A/YXBwaWQ9aGlnaGxhbmRlcjtzbT0xO3c9ODAwO2lsPXBsYW5l/http://globalfinance.zenfs.com/en_us/Finance/US_AFTP_GlobeNewsWire_EmailNotif_LIVE/iqstel-inc.jpg" />


The shift to 5G from a few ‘test’ cities to full global expansion has begun and iQSTEL, Inc. is at the forefront of this new telecommunications wave. This new wave is bigger than 3G and 4G combined as it will redefine the telecommunications landscape. Grand View Research, Inc. estimates the 5G system integration market size to reach upwards of $43 Billion by 2027. The addition of Mr. Jose Antonio Abdo is a key component of iQSTEL, Inc.’s expansion plans.

Mr. Jose Antonio Abdo is well known throughout Central and South America, closing major telecommunications infrastructure development contracts with local and international companies. His expertise in sales and business development including Tier 1, submarine cable, ISP and CATV operators will position iQSTEL, Inc. for major expansion across the region.

Mr. Iglesias, the Company’s CEO, stated: “The joining of Jose Antonio Abdo as an Advisor to the Board is a pivotal point for the Company’s organic growth and acquisition strategy in the 5G infrastructure space, particularly in Latin America. Mr. Abdo brings over 30 years of Senior-Level Executive Experience from such infrastructure giants as Global Crossing, AT&T and others. His expertise in submarine cable and Backhaul is unrivaled in the region. During his tenure with these world-class companies, he has led infrastructure acquisitions, deployments, and carrier sales teams through many types of projects.”

“Mr. Abdo’s experience will play a key role in sourcing new 5G infrastructure investment and acquisition opportunities for the Company. With the advent of IoT (Internet of Things) and the ever-increasing demand for multimedia services, it is clear that 5G infrastructure will be a major source of growth in the coming years. Mr. Abdo’s incorporation will put iQSTEL in a key position to be a major player in Latin America,” Mr. Iglesias, the company’s CEO, continued.

IoT end-user spending is projected to surpass $1.5 Billion by 2025 (Statista.com) and the supporting infrastructure deployment will provide significant revenue generating opportunities for iQSTEL, Inc.

About iQSTEL, Inc.:

iQSTEL (IQST) www.iQSTEL.com is a technology company offering a wide array of services to the Telecommunications Industry. These include services to International Long-Distance Telecommunications Operators (ILD Wholesale), Retail and Corporate markets (ILD Retail), Submarine Fiber Optic Network capacity, Satellite Communications services, Mobile Virtual Network Operator (MVNO) services, Internet of Things (IoT) technology solutions, Data Center facilities capacity leasing, and Blockchain solutions for the Telecommunications industry.

About Etelix.com USA, LLC:

Etelix.com USA LLC www.etelix.com is a wholly owned subsidiary of iQSTEL Inc. Etelix.com USA, LLC is a Miami, Florida-based international telecom carrier founded in 2008 that provides telecom and technology solutions worldwide, with commercial presences in North America, Latin America, and Europe. Enabled by its 214-license granted by the Federal Communications Commission (FCC), Etelix provides International Long-Distance voice services for Telecommunications Operators (ILD Wholesale), and Submarine Fiber Optic Network capacity for internet (4G and 5G). Etelix was founded in 2008 and has been profitable since inception.

About SwissLink Carrier AG:

SwissLink Carrier AG www.swisslink-carrier.com is a 51% owned subsidiary of iQSTEL Inc. SwissLink Carrier AG is a Switzerland based international Telecommunications Carrier founded in 2015 providing international VoIP connectivity worldwide, with commercial presences in Europe, CIS and Latin America. SwissLink Carrier AG is a Swiss licensed Operator, having a domestic Interconnect with Swisscom, allowing their international Carrier Customers direct terminations via SwissLink into all Switzerland Fix & Mobile Networks. Since the takeover from Swissphone in November 2018 and the rename into SwissLink, they operate on a profitable level.

Safe Harbor Statement: Statements in this news release may be "forward-looking statements". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and iQSTEL Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

Attachment

iQSTEL, Inc.

iQSTEL, Inc.
IR US Phone: [phone]
IR Email: [e-mail]
www.iqstel.com, www.swisslink-carrier.com, and www.etelix.com

[gumzsa]

gn pros

[gumzsa]

MCIC .0028 new 52wh today been holding

[TradeForProfits]

$PBIO from $3.25 to $2.55, load time again imo, #CBD water-soluble platform news last week:



https://finance.yahoo.com/news/pressure-biosciences-accelerating-rollout-proprietary-131500938.html

Pressure BioSciences Accelerating Rollout of Proprietary UST Platform for Water-Soluble CBD with Planned Release of Additional BaroShear Instrument
PR Newswire PR NewswireJanuary 30, 2020
Introduction of New Benchtop, R&D Scale, UST-Based "BaroShear Mini" in Q3 2020 Expected to Speed Market Penetration of PBI's UST Platform for Processing CBD and Other Oils into Stable, High Quality, Water-Soluble Nanoemulsions

New Instrument for Product Formulation and Development to Address Many Large and Diverse Markets

SOUTH EASTON, Mass., Jan. 30, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company plans to release a benchtop, R&D scale, Ultra Shear Technology™ ("UST™")-based BaroShear instrument to the market in the third quarter of 2020. The Company believes this new instrument will address a significant un-met need in product formulation and development laboratories in the cannabis, cosmetics, nutraceuticals, pharmaceuticals, and other large and diverse markets for processing CBD and other oils into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water.

CBD and other cannabinoids are extracted from the hemp plant in an oil form. The water-based biology of human bodies has difficulty accessing and absorbing oily molecules from the surface of ingested or topically applied hemp oil droplets. The ultra-low droplet sizes created by UST in nanoemulsions are designed to deliver levels of bioavailability and effectiveness that far exceed the dosing efficiencies achieved from today's macro or microemulsions of CBD Oil.

Kenneth F. Micciche, Director of PBI's UST Program, said: "We are very excited about the planned release later this year of the third instrument in the BaroShear product family. The aggressive marketing campaign we have underway for the pre-sale of our BaroShear K45 system and for the 2021 release of our industrial-scale BaroShear Max instrument has been well received by manufacturing laboratories. However, it has become apparent that product research and development labs prefer a smaller, bench-top, lower price-point, minimal throughput UST-based instrument. The BaroShear Mini clearly answers that need and will do so without cannibalizing sales to larger manufacturing facilities. We believe this new instrument will add significantly to PBI's revenue in 2020."

Richard T. Schumacher, President and CEO of PBI commented: "It has become apparent that Pressure BioSciences' breakthrough UST platform is a potential market-changing technology enabling a new generation of CBD and other cannabinoid products to more effectively meet consumer and supplier objectives. By delivering effective water solubility of cannabinoids, PBI's UST offers the promise of high absorption rates and bioavailability from ingestion or topical application of cannabinoid products. Most importantly, this delivers new confidence in controlled, safe and effective dosing for consumers. It also offers substantial cost reductions achieved as suppliers can eliminate the overloading of CBD and other cannabinoids into products, previously required to achieve targeted dosing levels."

Jeffrey N. Peterson, PBI Board Chairman, said: "Our innovation of the UST platform offers the potential to allow a universe of valuable materials that exist as oils (and thus do not naturally mix with water) to be delivered in effectively water-soluble preparations that can be easily absorbed by the water-based biology of humans and other animals, or applied in industrial and consumer applications, without requiring heavy use of undesirable chemical additives."

Mr. Peterson continued: "We believe that PBI will transform a vast range of applications with UST, that extend across multiple very large markets from dairy and other foods/beverages, to pharmaceuticals, nutraceuticals, and industrial applications. This is the technology platform that we believe will propel PBI into multi-billion dollar market opportunities, with resulting market value realization for our shareholders."

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following website link:

http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.

Cision
Cision
More
View original content:http://www.prnewswire.com/news-releases/pressure-biosciences-accelerating-rollout-of-proprietary-ust-platform-for-water-soluble-cbd-with-planned-release-of-additional-baroshear-instrument-300996081.html

SOURCE Pressure BioSciences, Inc

[gumzsa]

gm pros

[gumzsa]

gn pros

[TradeForProfits]

$MCOA $0.04 chart bounce area, grows #hempSMART brand, attending #LasVegas #CBD conference:

https://www.stockscores.com/charts/charts/?ticker=mcoa

https://finance.yahoo.com/news/hempsmart-subsidiary-marijuana-company-america-180000077.html

hempSMART™, Subsidiary of Marijuana Company of America, Releases Global Sales and Marketing Strategy for 2020
PR Newswire PR NewswireFebruary 5, 2020
- hempSMART will participate in the International CBD Expo in Las Vegas. This is the kick-off of a year-long promotional tour to strengthen brand awareness and foster sales

- hempSMART is creating a new line of products branded "smart. - powered by hempSMART", as an expansion of the hempSMART™ label

- hempSMART develops a new look and feel to bolster brand recognition

ESCONDIDO, Calif., Feb. 5, 2020 /PRNewswire/ -- Marijuana Company of America, Inc. ("MCOA" or the "Company") (OTCQB: MCOA), an innovative hemp and cannabis corporation, is pleased to announce hempSMART's overview for global sales and marketing strategy for 2020.

Marijuana Company of America (PRNewsfoto/Marijuana Company of America)
Marijuana Company of America (PRNewsfoto/Marijuana Company of America)
More
Jesus Quintero, the Company's Principal Executive Officer and Chief Financial Officer, said, "hempSMART is focused on developing new marketing and distribution strategies that will help our Company grow. Our objective is to make our brand stronger and more competitive, and to open new channels of distribution both in the US and abroad."

HempSMART™ will participate in the USA CBD Conference in Las Vegas, February 12 -15, 2020 at the Las Vegas Convention Center. This is the Company's first participation in an industry trade show and it is the kick-off to initiate an international tour of industry-focused conferences, where hempSMART will connect with over 11,000 attendees in each regional city and position the hempSMART and smart. brands as strong industry leaders.

The new product line, branded as "smart. – powered by hempSMART" is directed at young, active consumers who are looking for high quality CBD to enhance their lifestyle and wellbeing. The smart. product line has created a fresh look at affordable prices that will differentiate us from the crowded marketplace.

Ms. Gloria Albarran Lynch, Global Marketing and Sales Manager will be leading the hempSMART marketing strategy, "With this new rebranding, our premium-quality hempSMART™ products will now be positioned to engage a larger audience of potential customers. With the strength of the CBD wellness and beauty markets that are expected to be worth as much as $25 billion globally in the next decade, we intend to take full advantage of this tremendous opportunity and take a leading position in this expanding market. HempSMART is focused on becoming a true power brand, backed by premium products that have been very well received by our customers. We will support this initiative with a solid marketing plan for the year that includes promotional activities across social media platforms and through sponsored events. At hempSMART we are really excited about the new products we are about to unveil under the umbrella of the new "smart." line. We are also reviewing and improving our classic product line, to ensure that we remain at the cutting edge of the industry. More details on these new products will be released in the near future."

HempSMART™ will join the CBD, Beauty, and Sales convention circuit across the country and into Mexico and UK. We are starting this new year with renewed strength, and we will continue to grow and expand, with new marketing and distribution strategies to support our growth. The trade show tour will give us increased exposure, brand positioning and sales expansion, while the network marketing group continues to grow.

Cision
Cision
More
View original content to download multimedia:http://www.prnewswire.com/news-releases/hempsmart--subsidiary-of-marijuana-company-of-america-releases-global-sales-and-marketing-strategy-for-2020-300999617.html

SOURCE Marijuana Company of America, Inc.

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gn pros

[gumzsa]

IXOG .0119 custodianship

Case Information

A-20-809643-C | Synergy Management Group, Plaintiff(s) vs. Index Oil and Gas Inc., Defendant(s)

Case Number
A-20-809643-C

Court
Department 18

Judicial Officer
Holthus, Mary Kay

File Date
02/03/2020

Case Type
Other Civil Matters

Case Status
Open

Party
Plaintiff
Synergy Management Group


Active Attorneys

Lead Attorney
Shafer, Jay A.
Retained

Defendant
Index Oil and Gas Inc.


Events and Hearings

02/03/2020 Complaint

Complaint - COMP (CIV)

Comment
Application for Appointment of Custodian
02/03/2020 Initial Appearance Fee Disclosure

[gumzsa]

DFCO .0415 News

Dalrada Completes Acquisition of Software Development Company

HENDERSON, Nev., Feb. 3, 2020 /PRNewswire/ -- Dalrada Financial Corporation (OTC Pink: DFCO), is pleased to announce that it has completed the acquisition of Prakat Solutions, Inc. in an all stock swap deal. The acquisition strengthens Dalrada's engineering & healthcare solutions providing enhanced real-time monitoring and customer experience platforms, along with opportunities to increase revenues through technology implementations.

Prakat India provides the wide range of capabilities to support Dalrada customers by setting up dedicated call centers, automated service delivery offerings, and a new market potential for the company's products and services. "When we set out to build our renewed business model, we knew it needed a global footprint, and most importantly the right personnel to realize our vision. We are confident that Prakat's management team will continue to excel and complement our solutions," said Brian Bonar, CEO of Dalrada.

Prakat is headquartered in Bangalore, India and maintains offices in Denver, Colorado and Irving, Texas. The team provides end to end product engineering services in a variety of fields including banking and financial services, telecom, retail, healthcare, manufacturing, legal, and IT infrastructure. An ISO 9001-certified company with a customer base that includes several Fortune 1000 clients, with service offerings in software engineering, mobile development, data analytics, artificial intelligence and data science, and accessibility engineering.

The company has developed a sales strategy to target US-based opportunities for project-based and staff-augmentation solutions, and soon will be opening up an office in California to facilitate operations. With an established pipeline to tap into and the necessary support from Dalrada, Prakat will have a strong competitive advantage to offer unique and novel business solutions. "This is another revenue stream that we will capitalize on, providing end-to-end services for our products. It can be positioned as a package or a la carte, with tiers of skillsets and experience based on the customer need," continued Bonar.

The deal is expected to be accretive to earnings for quarter ending March 31, 2020.

About Dalrada Financial

Dalrada Financial Corp. (OTC Pink: DFCO) solves real-world problems by producing innovation-focused and technologically-centered solutions on a global level. Delivering next-generation manufacturing, engineering, and healthcare products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of financial capital. The company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. For more information, please visit www.dalrada.com or call 1-858-283-1253.

About Prakat Solutions

Prakat is a technology solutions company specializing in test engineering, accessibility engineering, product engineering and application modernization. Prakat partners with clients to create a transparent, value-based relationship, leveraging the extensive experience of its team to provide innovative solutions in a wide range of technology domains that enable customers to successfully attain their business goals. The Prakat work culture is truly based on the belief, "we believe in what we do; we do what we love." Prakat is an ISO 9001-certified company with several Fortune 1000 customers. With its main engineering center in Bangalore, India, the company also has offices in Fort Worth and Denver. The Prakat team provides end-to-end product engineering services across various domains including banking and financial services, telecom, retail, healthcare, manufacturing, legal, and IT infrastructure. For more information, please visit www.prakat.com.

Disclaimer

Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.

https://c212.net/c/img/favicon.png?sn=LA07384&sd=2020-02-03 View original content:http://www.prnewswire.com/news-releases/dalrada-completes-acquisition-of-software-development-company-300997395.html

SOURCE Dalrada Financial Corp.

[gumzsa]

gm pros

[gumzsa]

IXOG .01

[BottomBounce]

$NIO NIO NYSE IPO Highlight https://vimeo.com/298211788

[BottomBounce]

$CHK Chesapeake Energy in Louisiana
Chesapeake began developing natural gas in Louisiana’s Haynesville Shale in 2008 and continues building strong relationships with the region’s leaders and residents. Since the development of the Haynesville Shale, nine Northwest Louisiana parishes have become significant drivers for the state's economy and royalty owners. We remain committed to supporting the communities where we live and work while reducing our environmental footprint through efficient drilling, reduced air emissions and less surface activity. http://www.chk.com/Documents/operations/Louisiana-fact-sheet.pdf

[gumzsa]

DFCO .0415 News audited financials filed



Dalrada Files 10-K and Audited Financials

HENDERSON, Nev., Jan. 31, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO) announced today that it has filed its annual report on Form 10-K, including its audited consolidated financial statements for years ended June 30, 2019 and June 30, 2018. The company reported a net income of $365,850 for Fiscal 2019 compared to a net loss of $1,037,221 for Fiscal 2018, as a result of reducing its tax liabilities by $2,264,340.

With the company now focused more than ever on ensuring long-term success, Brian Bonar, Dalrada's Chief Executive Officer, is confident in the direction the organization is ready to take. "The completion of our annual financial and business performance filing including our audited financials is a critical step for our company. It allows us to share our status, future direction, and be even more dedicated to growing our business offerings," he said.

Bonar added, "I want to thank our investors, shareholders, customers, and our expanding team for their patience during this process. We are confident that our business model as well as our industry-leading science, engineering, and technology solutions are poised to deliver lasting value to our shareholders."

Dalrada has taken great strides in recent months to set a future course of delivering on its innovation-centric promise of making a true global impact. "We have focused on gathering the right pieces to support our low carbon, clean energy machines and creating healthcare solutions with a technology-driven global business model to drive immediate growth and profitability," said Bonar. "While we have significant work ahead of us, we are looking forward to the opportunities and continuing to progress," he concluded.

The company is now focused on completing filings for its quarterly reports on Form 10-Q for quarters ended September 30 and December 31, 2019.

About Dalrada Financial

Dalrada Financial Corp. (OTC Pink: DFCO) solves real-world problems by producing innovation-focused and technologically-centered solutions on a global level. Delivering next-generation manufacturing, engineering, and healthcare products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of financial capital. The company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. For more information, please visit www.dalrada.com or call 1-858-283-1253.

Disclaimer

Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.



https://c212.net/c/img/favicon.png?sn=LA06275&sd=2020-01-31 View original content:http://www.prnewswire.com/news-releases/dalrada-files-10-k-and-audited-financials-300996727.html

[gumzsa]

gm pros

[TradeForProfits]

$PBIO water soluble #CBD platform expansion, larger market reach:

https://finance.yahoo.com/news/pressure-biosciences-accelerating-rollout-proprietary-131500938.html

Pressure BioSciences Accelerating Rollout of Proprietary UST Platform for Water-Soluble CBD with Planned Release of Additional BaroShear Instrument
PR Newswire PR NewswireJanuary 30, 2020
Introduction of New Benchtop, R&D Scale, UST-Based "BaroShear Mini" in Q3 2020 Expected to Speed Market Penetration of PBI's UST Platform for Processing CBD and Other Oils into Stable, High Quality, Water-Soluble Nanoemulsions

New Instrument for Product Formulation and Development to Address Many Large and Diverse Markets

SOUTH EASTON, Mass., Jan. 30, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company plans to release a benchtop, R&D scale, Ultra Shear Technology™ ("UST™")-based BaroShear instrument to the market in the third quarter of 2020. The Company believes this new instrument will address a significant un-met need in product formulation and development laboratories in the cannabis, cosmetics, nutraceuticals, pharmaceuticals, and other large and diverse markets for processing CBD and other oils into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water.

CBD and other cannabinoids are extracted from the hemp plant in an oil form. The water-based biology of human bodies has difficulty accessing and absorbing oily molecules from the surface of ingested or topically applied hemp oil droplets. The ultra-low droplet sizes created by UST in nanoemulsions are designed to deliver levels of bioavailability and effectiveness that far exceed the dosing efficiencies achieved from today's macro or microemulsions of CBD Oil.

Kenneth F. Micciche, Director of PBI's UST Program, said: "We are very excited about the planned release later this year of the third instrument in the BaroShear product family. The aggressive marketing campaign we have underway for the pre-sale of our BaroShear K45 system and for the 2021 release of our industrial-scale BaroShear Max instrument has been well received by manufacturing laboratories. However, it has become apparent that product research and development labs prefer a smaller, bench-top, lower price-point, minimal throughput UST-based instrument. The BaroShear Mini clearly answers that need and will do so without cannibalizing sales to larger manufacturing facilities. We believe this new instrument will add significantly to PBI's revenue in 2020."

Richard T. Schumacher, President and CEO of PBI commented: "It has become apparent that Pressure BioSciences' breakthrough UST platform is a potential market-changing technology enabling a new generation of CBD and other cannabinoid products to more effectively meet consumer and supplier objectives. By delivering effective water solubility of cannabinoids, PBI's UST offers the promise of high absorption rates and bioavailability from ingestion or topical application of cannabinoid products. Most importantly, this delivers new confidence in controlled, safe and effective dosing for consumers. It also offers substantial cost reductions achieved as suppliers can eliminate the overloading of CBD and other cannabinoids into products, previously required to achieve targeted dosing levels."

Jeffrey N. Peterson, PBI Board Chairman, said: "Our innovation of the UST platform offers the potential to allow a universe of valuable materials that exist as oils (and thus do not naturally mix with water) to be delivered in effectively water-soluble preparations that can be easily absorbed by the water-based biology of humans and other animals, or applied in industrial and consumer applications, without requiring heavy use of undesirable chemical additives."

Mr. Peterson continued: "We believe that PBI will transform a vast range of applications with UST, that extend across multiple very large markets from dairy and other foods/beverages, to pharmaceuticals, nutraceuticals, and industrial applications. This is the technology platform that we believe will propel PBI into multi-billion dollar market opportunities, with resulting market value realization for our shareholders."

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

[TradeForProfits]

$IQST #5G company ready for breakout again? $22M 2019 revenue:

https://finance.yahoo.com/news/iqstel-inc-announces-swisslink-fy-103010595.html

iQSTEL, Inc. Announces Swisslink FY-2019 Revenue Of $5,610,633 for its First Year of Acquisition
GlobeNewswire GlobeNewswireJanuary 30, 2020
NEW YORK, NY, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – iQSTEL, Inc. (IQST) announces that its 51% Swiss subsidiary generated over $5.6 million in revenue for 2019.

Mr. Iglesias, the Company’s CEO, stated: “The acquisition strategy we have set out for iQSTEL is showing early success. This vertical acquisition has been key since it gives us bare-bottom-cost-based voice routing interconnection into European cities and major carriers we did not previously have. Additionally, we have been able to quickly implement synergies in our admin, IT and operating departments. This acquisition and integration has been not only strategic in allowing us to provide cross-selling opportunities with Etelix, but more importantly, we believe it enhances our carrier network backbone, which we expect to be fundamental as we step up cross-selling opportunities with soon-to-be-announced services and acquisitions in other horizontal strategic solutions in the 5G, blockchain-based carrier payment, as well as DID portability space. Full-year revenue on an additive basis for both subsidiaries reached $21,938,503 for 2019. We expect organic growth in these 2 subsidiaries to be in the 20-30% YOY, but more importantly, will be the backbone of our transitioning into a full-service cloud-based 21st century communications provider in the near and mid-term.”

About iQSTEL Inc.:

iQSTEL (IQST) (www.iQSTEL.com) is a technology company offering a wide array of services to the Telecommunications Industry. These include services to International Long-Distance Telecommunications Operators (ILD Wholesale), Retail and Corporate markets (ILD Retail), Submarine Fiber Optic Network capacity, Satellite Communications services, Mobile Virtual Network Operator (MVNO) services, Internet of Things (IoT) technology solutions, Data Center facilities capacity leasing, and Blockchain solutions for the Telecommunications industry.

About Etelix.com USA, LLC:

Etelix.com USA LLC (www.etelix.com) is a wholly owned subsidiary of iQSTEL, Inc. Etelix.com USA, LLC is a Miami, Florida-based international telecom carrier founded in 2008 that provides telecom and technology solutions worldwide, with a commercial presence in North America, Latin America, and Europe. Enabled by its 214-license granted by the Federal Communications Commission (FCC), Etelix provides International Long-Distance voice services for Telecommunications Operators (ILD Wholesale), and Submarine Fiber Optic Network capacity for internet (4G and 5G). Etelix was founded in 2008 and has been profitable since inception.

About SwissLink Carrier AG:

SwissLink Carrier AG (www.swisslink-carrier.com) is a 51% owned subsidiary of iQSTEL, Inc. SwissLink Carrier AG is a Switzerland based international Telecommunications Carrier founded in 2015 providing international VoIP connectivity worldwide, with commercial presence in Europe, CIS and Latin America. SwissLink Carrier AG is a Swiss licensed Operator, having a domestic Interconnect with Swisscom, allowing their international Carrier Customers direct terminations via SwissLink into all Switzerland Fix & Mobile Networks. Since the takeover from Swissphone in November 2018 and the rename into SwissLink, they operate on a profitable level.

[TradeForProfits]

$EDXC #CBD #HEMP invited for interview at NASDAQ site:

https://finance.yahoo.com/news/cbd-unlimited-invited-exclusive-interview-103010554.html

CBD Unlimited Invited for Exclusive Interview at Nasdaq Market Site in Times Square
GlobeNewswire GlobeNewswireJanuary 29, 2020
CAVE CREEK, AZ, Jan. 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce the Company has been invited for an exclusive interview taking place at the Nasdaq MarketSite in Times Square, New York City on Wednesday, February 5th, 2020.

Mr. Todd Davis, CBD Unlimited’s Chairman and CEO, will be addressing the Company’s recent business developments and rapid growth of the CBD market. Once recorded, the interview will be released and immediately accessible to the public. This interview comes quickly after the Company’s new product suite launch and announcements of news related to additional international markets.

“We are thrilled to have the opportunity to share our recent developments and outlook for 2020 at the Nasdaq MarketSite in New York City,” commented Todd Davis, CEO and Chairman of CBD Unlimited. “2019 proved to be a tremendous year for our Company and we look forward to updating our audience on several new initiatives. Our team continues to cohesively exceed expectations while innovating new products and delivering to our customers. We look forward to sharing our updates directly from one of the top exchanges in the world right in the heart of New York City.”

About CBD Unlimited, Inc.

CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.

In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.

Website: www.cbdunlimited.com

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.




Contact:
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
[e-mail]
480-595-6900

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[TradeForProfits]

$PBIO $2.4M Nanoemulsification System for Water-Soluble #CBD Oil news:

https://finance.yahoo.com/news/pressure-biosciences-announces-significant-order-131500666.html

Pressure BioSciences Announces Significant New Order and Near Sellout on Revolutionary Nanoemulsification System for Water-Soluble CBD Oil
PR Newswire PR NewswireJanuary 24, 2020
New Order for Six BaroShear K45 Systems Brings Total to Nine Orders Received for Company's New Ultra Shear Technology™ Based Platform. Additional Orders Expected Shortly Would Sell Out Planned Initial Build of 12 Systems, with Approximate Total Value of $2.4 Million.

SOUTH EASTON, Mass., Jan. 24, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company has received a purchase order from a new customer for six (6) proprietary Ultra Shear Technology™ ("UST™")-based nanoemulsification systems for processing CBD Oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. Such nanoemulsions are expected to exhibit levels of bioavailability that far exceed the bioavailability of today's macro or microemulsions of CBD Oil.

CBD is extracted from the hemp plant in an oil. As with any oil-based product, it is difficult for the water-based biology of the human body to access and absorb CBD molecules from relatively large hemp oil drops. This poor and variable absorption of CBD results in low and variable bioavailability of the CBD molecule in the body. Low or widely varying levels of absorption and bioavailability of CBD adversely impacts the effective delivery of the potential benefits of many CBD products on the market today.

The purchase order for six BaroShear K45 systems was placed by Mr. Jason Ellis, President of Vegas CBD Factory. When asked about his order, Mr. Ellis commented: "As consumers rush to try, use and adopt CBD-infused products, it is important to realize that the CBD in the product should be in a high-quality, water-soluble and reliably dosed form. Proper dosing levels with high bioavailability of CBD from ingested products will in turn increase the chance for the consumer to achieve and optimize the potential beneficial effects of the CBD."

Mr. Ellis continued: "Understanding and addressing this issue is a pivotal challenge for the CBD industry. At Vegas CBD Factory, we have spent a significant amount of time searching for the best method available to make high-quality nanoemulsions of CBD oil. We have concluded that PBI's proprietary UST-based platform is the best technology available for achieving optimized dosing and have concluded that to give our customers the best CBD-based product, we should be processing our material using the BaroShear K45 nanoemulsification platform. Consequently, we have placed an initial order for six K45 systems."

Kenneth F. Micciche, Director of PBI's UST Program, said: "Recent BaroShear K45 instrument development efforts and demonstrations have propelled a refreshed sales effort for this innovative instrument system since the beginning of 2020. In the first three weeks of this new marketing initiative, we have secured an order for six BaroShear K45 systems and have genuine interest in additional purchases for many more units. We are excited and inspired to see our aggressive new marketing efforts for the BaroShear K45 taking such a strong early hold, and we anticipate further significant orders in the days and weeks ahead."

Richard T. Schumacher, President and CEO of PBI, commented: "In addition to the new order for six BaroShear K45 systems, there are numerous additional groups who have shown high levels of interest in acquiring the new BaroShear K45 nanoemulsification system. Our team is diligently following up with these interested parties; we believe that several of these groups will be placing purchase orders with us in the very near future. These are very exciting times for all PBI stakeholders."

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

[gumzsa]

gm pros

[gumzsa]

gn pros

[BottomBounce]

$ALYI ALYI - Alternet Systems Preparing For $79 Billion African Hemp Market Opportunity
https://www.barchart.com/story/stocks/quotes/ALYI/news/3640523/alyi-alternet-systems-prepares-for-79-billion-african-hemp-market-opportunity